查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613164

全球顯影劑市場（按類型、治療、給藥途徑、應用、最終用戶、適應症）：未來預測（2025-2030）

Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年顯影劑市值為36.7億美元，預計2024年將達到40.2億美元，複合年成長率為9.75%，到2030年將達到70.4億美元。

造影顯影劑是醫療圖像中必不可少的試劑，可提高體內結構和液體的可見度，並在 X 光、MRI 和電腦斷層掃描等診斷過程中發揮重要作用。對這種藥物的需求源於它能夠提供清晰、詳細的影像並幫助準確診斷和管理各種醫療狀況。最終用途廣泛，包括醫院、診斷影像中心和專科診所，並用於從放射學、循環系統學到胃腸道成像的各種醫療領域。

主要市場統計
基準年[2023] 36.7億美元
預測年份 [2024] 40.2億美元
預測年份 [2030] 70.4億美元
複合年成長率（%） 9.75%

顯影劑市場受到多種成長要素的影響，包括慢性病的增加、影像技術的進步以及需要頻繁診斷影像的老年人口的增加。機會包括開發更安全、更有效的顯影劑、針對特定醫療應用的技術創新以及增強的診斷影像技術。公司應探索新興市場的潛力，這些市場是由醫療基礎設施改善和對早期診斷益處的認知不斷提高所推動的。

然而，市場面臨顯影劑副作用風險、嚴格的監管核准以及與先進診斷影像相關的高成本等挑戰。解決這些限制需要對研究和開發進行投資，以提高藥物的安全性和具有成本效益的解決方案。

創新和研發的機會在於開發副作用較少的新型生物相容性顯影劑，以及研究減少傳統藥物所需劑量的成像技術。此外，探索人工智慧整合影像分析可以提高診斷準確性和業務效率。根據精準醫療的趨勢，產業相關人員應專注於個人化醫療方法，根據個別患者的需求設計藥物。儘管面臨挑戰，顯影劑市場仍將帶來巨大的成長機會，持續的技術和產品進步將推動未來的機會。公司需要策略性地了解這些趨勢，以利用成長潛力，同時應對複雜的市場動態。

市場動態：揭示快速發展的顯影劑市場的關鍵市場洞察

供需的動態交互作用正在改變顯影劑市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 癌症和心血管疾病盛行率上升
    • 消費者對先進影像技術的偏好日益成長
    • 醫療基礎建設投資快速成長
  • 市場限制因素
    • 研究開發更安全、更有效的顯影劑高成本
  • 市場機會
    • 加大新型顯影劑的創新與開發力度
    • 擴大在影像診斷中表現出優異性能的奈米粒子的開發
  • 市場挑戰
    • 由於顯影劑的潛在副作用，人們越來越擔心患者的安全

波特的五力：駕馭顯影劑市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。它為評估公司的競爭力和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解顯影劑市場的外部影響

外部宏觀環境因素對顯影劑市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解顯影劑市場的競爭格局

顯影劑市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：顯影劑市場供應商的績效評估

FPNV定位矩陣是評估顯影劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製顯影劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，顯影劑市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估市場範圍和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析最近的產品發布、開拓的地區、關鍵產業進展以及塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1. 目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 哪些收益來源和策略機會推動供應商的進入/退出策略？

目錄

第1章簡介

第2章 分析方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和心血管疾病的發生率上升
      • 消費者對先進影像技術的偏好日益成長
      • 醫療基礎建設投資快速成長
    • 抑制因素
      • 研發更安全、更有效的顯影劑高成本
    • 機會
      • 加大新型顯影劑的創新與開發力度
      • 在成像過程中具有卓越性能的奈米粒子的開發進展
    • 任務
      • 由於顯影劑的潛在副作用，增加了患者安全問題
  • 市場區隔分析
    • 類型：對準確診斷方法的需求增加了碘造影顯影劑的使用
    • 應用：介入性放射線顯影劑採用率高
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 經濟因素
    • 社會因素
    • 技術因素
    • 法律因素
    • 環境因素

第6章顯影劑市場：依類型

  • 鋇基顯影劑
  • 钆基顯影劑
  • 顯影劑
  • 微氣泡顯影劑

第7章顯影劑市場：依程序

  • 磁振造影
  • 超音波
  • X 光與電腦斷層掃描

第8章比較顯影劑市場：依管理途徑

  • 血管內給藥
  • 口服給藥
  • 直腸途徑

第9章顯影劑市場：依應用分類

  • 介入性心臟病學
  • 介入放射學
  • 放射治療

第 10 章比較顯影劑市場：依最終用戶分類

  • 門診手術中心
  • 影像診斷中心
  • 醫院/診所

第11章顯影劑市場：依適應症分類

  • 癌症
  • 心血管疾病
  • 胃腸道疾病
  • 肌肉骨骼疾病
  • 腎臟疾病
  • 神經系統疾病

第12章美洲顯影劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太顯影劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲顯影劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • 費森尤斯卡比 (Fresenius Kabi) 推出新型非專利MRI顯影劑
    • Imagion 擴大與西門子在 MRI顯影劑的合作關係
    • GE Medical 推出 MRI 試劑 Pixxoscan（钆布醇），擴大顯影劑組合
  • 戰略分析和建議

公司名單

  • Acro Lifesciences (I) Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Covis Group
  • Daiichi Sankyo Co. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare Co., Ltd.
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • JB Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • M.Biotech Limited
  • Miltenyi Biotec BV & Co. KG
  • Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • nanoPET Pharma GmbH
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • Vitalquan, LLC
Product Code: MRR-434CCDA04E9E

The Contrast Media Market was valued at USD 3.67 billion in 2023, expected to reach USD 4.02 billion in 2024, and is projected to grow at a CAGR of 9.75%, to USD 7.04 billion by 2030.

Contrast media, essential agents in medical imaging, enhance the visibility of structures and fluids within the body, playing a crucial role in diagnostic procedures such as X-rays, MRI, and CT scans. The necessity of these agents stems from their ability to provide clear, detailed images, aiding in the accurate diagnosis and management of various medical conditions. They find applications across diverse medical fields, from radiology and cardiology to gastrointestinal imaging, with end-use spanning hospitals, diagnostic imaging centers, and specialized clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.67 billion
Estimated Year [2024] USD 4.02 billion
Forecast Year [2030] USD 7.04 billion
CAGR (%) 9.75%

The contrast media market is influenced by several growth factors, including the increasing prevalence of chronic diseases, advancements in imaging technology, and the rising geriatric population necessitating frequent diagnostic imaging. Opportunities arise from the development of safer, more effective contrast agents and innovations targeting specific medical applications and enhanced imaging techniques. Companies should explore the potential in emerging markets, driven by healthcare infrastructure improvements and increasing awareness of early diagnosis benefits.

However, the market faces challenges such as the risk of adverse reactions to contrast media, stringent regulatory approvals, and high costs associated with advanced imaging procedures. Addressing these limitations requires investment in research and development to enhance agent safety profiles and cost-effective solutions.

Innovation and research opportunities lie in the development of novel, biocompatible contrast agents with minimal side effects, as well as the investigation of imaging techniques that reduce the required doses of traditional agents. Additionally, exploring AI integration for image analysis can improve diagnostic accuracy and operational efficiency. Industry players should focus on personalized medicine approaches, designing agents tailored to individual patient needs, aligning with the trend toward precision healthcare. Despite challenges, the contrast media market presents substantial growth prospects, with ongoing technological and product advancements driving future opportunities. Businesses must strategically align themselves with these trends to capitalize on growth potential while navigating complex market dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contrast Media Market

The Contrast Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer and cardiovascular diseases
    • Increasing consumer preference toward advanced imaging technologies
    • Burgeoning investment in healthcare infrastructure
  • Market Restraints
    • High costs associated with research and development of safer and more effective contrast agents
  • Market Opportunities
    • Increasing innovations and development of new contrast agents
    • Growing development of nanoparticles offering superior performance in imaging procedures
  • Market Challenges
    • Rising patient safety concerns due to potential adverse reactions to contrast agents

Porter's Five Forces: A Strategic Tool for Navigating the Contrast Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contrast Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contrast Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contrast Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contrast Media Market

A detailed market share analysis in the Contrast Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contrast Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contrast Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contrast Media Market

A strategic analysis of the Contrast Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the Contrast Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Barium-Based Contrast Media, Gadolinium-Based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.
  • Based on Procedure, market is studied across Magnetic Resonance Imaging, Ultrasound, and X-ray & Computed Tomography.
  • Based on Route Of Administration, market is studied across Intravascular Route, Oral Route, and Rectal Route.
  • Based on Application, market is studied across Interventional Cardiology, Interventional Radiology, and Radiology.
  • Based on End-user, market is studied across Ambulatory Surgery Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.
  • Based on Disease Indication, market is studied across Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and cardiovascular diseases
      • 5.1.1.2. Increasing consumer preference toward advanced imaging technologies
      • 5.1.1.3. Burgeoning investment in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development of safer and more effective contrast agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing innovations and development of new contrast agents
      • 5.1.3.2. Growing development of nanoparticles offering superior performance in imaging procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Rising patient safety concerns due to potential adverse reactions to contrast agents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
    • 5.2.2. Application: High adoption of contrast media in interventional radiology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contrast Media Market, by Type

  • 6.1. Introduction
  • 6.2. Barium-Based Contrast Media
  • 6.3. Gadolinium-Based Contrast Media
  • 6.4. Iodinated Contrast Media
  • 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Procedure

  • 7.1. Introduction
  • 7.2. Magnetic Resonance Imaging
  • 7.3. Ultrasound
  • 7.4. X-ray & Computed Tomography

8. Contrast Media Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Intravascular Route
  • 8.3. Oral Route
  • 8.4. Rectal Route

9. Contrast Media Market, by Application

  • 9.1. Introduction
  • 9.2. Interventional Cardiology
  • 9.3. Interventional Radiology
  • 9.4. Radiology

10. Contrast Media Market, by End-user

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Contrast Media Market, by Disease Indication

  • 11.1. Introduction
  • 11.2. Cancer
  • 11.3. Cardiovascular Disorders
  • 11.4. Gastrointestinal Disorders
  • 11.5. Musculoskeletal Disorders
  • 11.6. Nephrological Disorders
  • 11.7. Neurological Disorders

12. Americas Contrast Media Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contrast Media Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Fresenius Kabi Debuts New Generic MRI Contrast Agent
    • 15.3.2. Imagion Expands Collaboration With Siemens On MRI Contrast Agent
    • 15.3.3. GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol)
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. Bayer AG
  • 3. Beijing Beilu Pharmaceutical Co., Ltd.
  • 4. Bracco Spa
  • 5. Covis Group
  • 6. Daiichi Sankyo Co. Ltd.
  • 7. Fuji Pharma Co. Ltd.
  • 8. GE Healthcare Co., Ltd.
  • 9. Guerbet SA
  • 10. iMAX Diagnostic Imaging Limited
  • 11. J. B. Chemicals & Pharmaceuticals Limited
  • 12. Jodas Expoim Pvt. Ltd.
  • 13. Lantheus Medical Imaging, Inc.
  • 14. M.Biotech Limited
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • 17. nanoPET Pharma GmbH
  • 18. SANOCHEMIA Pharmazeutika GmbH
  • 19. Spago Nanomedical AB
  • 20. Trivitron Healthcare
  • 21. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. CONTRAST MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRAST MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRAST MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023